Cargando…
ABBV-744 as a potential inhibitor of SARS-CoV-2 main protease enzyme against COVID-19
A new pathogen severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread worldwide and become pandemic with thousands new deaths and infected cases globally. To address coronavirus disease (COVID-19), currently no effective drug or vaccine is available. This necessity motivated us to e...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7794216/ https://www.ncbi.nlm.nih.gov/pubmed/33420186 http://dx.doi.org/10.1038/s41598-020-79918-3 |